MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$167,852K
Accounts receivable, net
$140,190K
Inventories, net
$105,124K
Prepaid inventory costs
$40,864K
Other prepaid and
current assets
$4,496K
Prepaid clinical
development costs
$4,044K
Property and equipment,
gross
$2,517K
Total current assets
$462,570K
Right of use operating
lease assets
$2,922K
Property and equipment,
net
$338K
Intangible assets
$56K
Less accumulated
depreciation and...
$2,179K
Total assets
$465,886K
Accumulated deficit
-$1,623,711K
Treasury stock, at cost
1,994,198 shares at...
$54,998K
Total liabilities and
stockholders' deficit
$465,886K
Total stockholders'
deficit
-$301,965K
Additional paid-in capital
$1,376,499K
Common stock, 0.001 par
value 480,000,000...
$245K
Total liabilities
$767,851K
Total current
liabilities
$300,810K
Royalty sale liability
$208,170K
Long-term debt
$152,219K
Convertible notes, net of
issuance costs
$97,260K
Other long-term
liabilities
$8,739K
Operating lease
liabilities
$653K
Accrued variable
consideration
$88,203K
Royalty sale liability
$87,596K
Accounts payable
$65,068K
Deferred revenue from
collaborations
$34,477K
Other accrued
liabilities
$19,249K
Accrued clinical
development costs
$4,115K
Operating lease
liabilities
$2,102K
Back
Back
Balance Sheet
source: myfinsight.com
Esperion Therapeutics, Inc. (ESPR)
Esperion Therapeutics, Inc. (ESPR)